(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $48880 | $47875 | $46568 | $44736 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2753086 | $2699258 | $2700042 | $2591499 |
Current liabilities | ||||
Accounts payable | ||||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $151523 | $49626 | $152711 | $41859 |
Long term debt | $131251 | $211908 | $117638 | $196711 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $2628125 | $2577076 | $2575031 | $2467757 |
Shareholders' equity | ||||
Retained earnings | $9366 | $93340 | $3103 | $92110 |
Other shareholder equity | -$3245 | $9683 | -$3057 | $10759 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $44736 | $38468 | $34508 | $32895 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2591499 | $2666376 | $2634444 | $2488491 |
Current liabilities | ||||
Accounts payable | ||||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $41859 | $13928 | $9526 | $8372 |
Long term debt | $196711 | $176205 | $173525 | $151368 |
Total noncurrent liabilities | $151368 | |||
Total debt | ||||
Total liabilities | $2467757 | $2544584 | $2516558 | $2375692 |
Shareholders' equity | ||||
Retained earnings | $92110 | $10196 | $82110 | $76294 |
Other shareholder equity | $10759 | -$3553 | $6440 | $7303 |
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $12165 | |||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1051 | |||
Interest expense | ||||
Net income | ||||
Net income | $2868 | |||
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $70226 | |||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $3266 | |||
Interest expense | ||||
Net income | ||||
Net income | $10298 | |||
Income (for common shares) |
(in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $1035 | $7304 | $8681 | -$2163 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$7528 | -$4676 | -$3868 | $9250 |
Effect of exchange rate | -$2596 | -$3506 | -$4386 | $1030 |
Change in cash and equivalents | -$102247 | -$35119 | -$22396 | -$44720 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $7304 | -$2163 | -$1182 | -$851 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$4676 | $9250 | $14516 | $18524 |
Effect of exchange rate | -$3506 | $1030 | $107 | -$2614 |
Change in cash and equivalents | -$35119 | -$44720 | $55817 | $154383 |
Market cap | $67.06B |
---|---|
Enterprise value | N/A |
Shares outstanding | 1.13B |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | 3.32% |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |